Thread by @SimonElmer2022

To the doctors and other medical professionals claiming they thought AstraZeneca’s experimental viral vector ‘vaccine’ was safe and effective, this is what we knew about this company even before you recommended or administered its injections to UK citizens. So why didn’t you?

The AstraZeneca ‘vaccine’ was developed in 2020 by the Oxford Vaccine Group, whose Director, Professor Andrew Pollard, is also Chair of the Joint Committee on Vaccination and Immunisation that advises UK health departments on the safety of vaccines. gov.uk/government/gro…

In 2010, AstraZeneca had paid $520 million in fines to settle charges by the US Federal Government for illegally marketing the anti-psychotic drug, Seroquel, to children and elderly patients for uses not approved by the Food and Drug Administration (FDA). abcnews.go.com/Politics/Healt…

In 2013, following his appointment as Chair of the JCVI by Jeremy Hunt, then the UK Minister for Health, Professor Pollard, who as head of the Oxford Vaccine Group had also developed the Meningitis B vaccine Bexsero, authorised its use on UK children.
ageofautism.com/2019/12/the-ub…

Professor Pollard’s authorisation of Bexsero was given despite significant safety signals for Kawasaki Disease in infants during the clinical trials for the vaccine, and the rarity of Group B meningococcal disease.
bmj.com/content/350/bm…

That same year, in 2013, it was revealed that pharmaceutical companies were paying UK doctors £40 million every year to promote their drugs. The UK office of AstraZeneca paid £671,400 in fees to 903 doctors plus £30,200 for their travel and hotel bills.
theguardian.com/society/2013/a…

Also in 2013, the Oxford Vaccine Group affiliated with Public Health England (PHE). Despite being the executive agency of the Department for Health and Social Care, PHE had received $7.46 million in grants from the Bill & Melinda Gates Foundation by 2015.
gatesfoundation.org/about/committe…

In 2016, AstraZeneca agreed to pay $5.5 million to settle charges of violating the Foreign Corrupt Practices Act by bribing doctors in China and Russia in order to boost sales of their pharmaceutical products.
statnews.com/pharmalot/2016…

In 2016, the Bill & Melinda Gates Foundation gave $36.9 million for research into vaccine development by a team that included the Oxford Vaccine Group, the developer in 2020 of the AstraZeneca ‘vaccine’, and which was headed by Professor Andrew Pollard.
ovg.ox.ac.uk/news/an-intern…

Professor Pollard’s academic employer, the University of Oxford, has received $63.47 million from the Bill & Melinda Gates Foundation (BMGF) since the ‘pandemic’ was declared in March 2020.
gatesfoundation.org/about/committe…

Professor Andrew Pollard’s own research laboratory is also funded by the Bill & Melinda Gates Foundation, which is therefore the primary employer of both the Chair of the JCVI and the Director of the team that developed the AstraZeneca ‘vaccine’.
researchgate.net/lab/Andrew-J-P…

Pollard is also a member of the National Institute for Biological Standards and Control (NIBSC) Scientific Advisory Committee, which advises the Medicines and Healthcare products Regulatory Agency (MHRA) that guarantees the safety of vaccines in the UK.
nibsc.org/about_us/scien…

In April 2018, it was revealed that AstraZeneca had paid €17.9 million in secret payments to ‘independent’ healthcare professionals to endorse their products, including the use of vaccines. There is nothing to indicate this systemic bribery has stopped.
thetimes.co.uk/article/20m-se…

In April 2020, Oxford University entered into a partnership with AstraZeneca to sell what subsequent deals established would be 400 million doses of its ‘vaccine’ in Europe, 700 million to the US and GAVI Vaccine Alliance, and 1 billion doses to India.
gavi.org/vaccineswork/w…

As a result of its ‘vaccine’ deals, AstraZeneca’s net profit in the second quarter of 2020 rose to £581.18 million, compared to just £99.94 million in the same quarter the previous year. Over the whole of 2020, product sales for AstraZeneca went up by 10%.
invezz.com/news/2020/07/3…

In September 2020, AstraZeneca and Oxford University’s COVID-19 ‘vaccine’ trial was paused after a UK participant suffered spinal cord inflammation. Yet it took a month to send the ‘vaccine’ trial safety data to the US Food and Drug Administration (FDA).
dailymail.co.uk/health/article…

In November 2020, it was revealed that AstraZeneca’s claim that its vaccine has an efficacy of 90% was based on a trial only administered to individuals up to 55 years of age, a demographic with a far lower chance of developing symptoms requiring a vaccine.ft.com/content/4583fb…

In December 2020, an interim analysis of trials of the ‘safety and efficacy’ of the AstraZeneca ‘vaccine’ was published in The Lancet. Among the funders of the trial was the Bill & Melinda Gates Foundation and AstraZeneca itself.
thelancet.com/journals/lance…

In April 2021, The Lancet estimated that although the AstraZeneca ‘vaccine’ has a relative risk reduction of 67%, the absolute risk reduction is only 1.9%. Neither come near the claims of 90% efficacy made by AstraZeneca or the doctors administering it. thelancet.com/journals/lanmi…

In May 2021, Transparency International Global Health accused AstraZeneca of a lack of transparency over its ‘vaccine’ trials, secret contracts with governments, and conducting ‘science by press release’.
transparency.org/en/press/covid…

By March 2021, blood clotting led Sweden, Latvia, France, Germany, Italy, Spain, Luxembourg, Cyprus, Portugal, Slovenia, Indonesia, the Netherlands, Ireland, Bulgaria, the Congo, Thailand, Romania, Iceland, Denmark, Norway and Austria to suspend its use.
aljazeera.com/news/2021/3/15…

In November 2021, AstraZeneca, which sold £1.64 billion of its ‘vaccine’, Vaxzevria, in the first 9 months of 2021, announced it was reneging on its promise to sell at cost ‘for the duration of the pandemic’, which it declared was in the ‘endemic phase’.
theguardian.com/business/2021/…

Since 2000, AstraZeneca has paid $1.381 billion in fines, $594m for healthcare offences, $556.2m in government-related offences under the False Claims Act, $198m for safety offences, $21m under the Foreign Corrupt Practices Act, and $5.52m for bribery.
violationtracker.goodjobsfirst.org/parent/astraze…

As of 25 August, 2022, the MHRA has received 246,183 reports of 872,333 adverse drug reactions to the AstraZeneca ‘vaccine’, of which 1,301 have resulted in death within 7 days of vaccination, with unknown thousands more after this arbitrary cut-off.
assets.publishing.service.gov.uk/government/upl…

On 1 June, 2022, both the Director of the Oxford Vaccine Group, Andrew Pollard, and the CEO of AstraZeneca, Pascal Soriot, were knighted in the Queen’s Birthday Honours List.

Given the climate of censorship, this post may be deleted and my account suspended. But these facts and more can be read in this article, which I published on 25 November 2020, a month before the MHRA granted the AZ ‘vaccine’ temporary authorisation.
architectsforsocialhousing.co.uk/2020/11/25/bre…

If you’re interested in this, you may be interested in my new book. Everything you ever wanted to know about the Great Reset (but were too afraid of being called a ‘conspiracy theorist’ to ask). Click on link for contents, preface and purchase options.
architectsforsocialhousing.co.uk/2022/09/28/the…